Institutional investors purchased a net $42.0 million shares of AZN during the quarter ended September 2016 and now own 13.07% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 9.7 Million shares of AstraZeneca
FIDELITY MANAGEMENT & RESEARCH C... Bought 5.3 Million shares of AstraZeneca
CLEARBRIDGE INVESTMENTS LLC Bought 5.2 Million shares of AstraZeneca